Suppr超能文献

大容量鞘内给药:对脑脊液压力的影响及安全问题

Large-Volume Intrathecal Administrations: Impact on CSF Pressure and Safety Implications.

作者信息

Belov Vasily, Appleton Janine, Levin Stepan, Giffenig Pilar, Durcanova Beata, Papisov Mikhail

机构信息

Massachusetts General Hospital, Boston, MA, United States.

Harvard Medical School, Boston, MA, United States.

出版信息

Front Neurosci. 2021 Apr 14;15:604197. doi: 10.3389/fnins.2021.604197. eCollection 2021.

Abstract

The increasing number of studies demonstrates the high potency of the intrathecal (IT) route for the delivery of biopharmaceuticals to the central nervous system (CNS). Our earlier data exhibited that both the infused volume and the infusion rate can regulate the initial disposition of the administered solute within the cerebrospinal fluid (CSF). This disposition is one of key factors in defining the subsequent transport of the solute to its intended target. On the other hand, fast additions of large volumes of liquid to the CSF inevitably raise the CSF pressure [a.k.a. intracranial pressure (ICP)], which may in turn lead to adverse reactions if the physiologically delimited threshold is exceeded. While long-term biological effects of elevated ICP (hydrocephalus) are known, the safety thresholds pertaining to short-term ICP elevations caused by IT administrations have not yet been characterized. This study aimed to investigate the dynamics of ICP in rats and non-human primates (NHPs) with respect to IT infusion rates and volumes. The safety regimes were estimated and analyzed across species to facilitate the development of translational large-volume IT therapies. The data revealed that the addition of a liquid to the CSF raised the ICP in a rate and volume-dependent manner. At low infusion rates (<0.12 ml/min in rats and <2 ml/min in NHPs), NHPs and rats displayed similar tolerance patterns. Specifically, safe accommodations of such added volumes were mainly facilitated by the accelerated pressure-dependent CSF drainage into the blood, with I stabilizing at different levels below the safety threshold of 28 ± 4 mm Hg in rats and 50 ± 5 mm Hg in NHPs. These ICPs were safely tolerated for extended durations (of at least 2-25 min). High infusion rates (including boluses) caused uncompensated exponential ICP elevations rapidly exceeding the safety thresholds. Their tolerance was species-dependent and was facilitated by the compensatory role of the varied components of craniospinal compliance while not excluding the possibility of other contributing factors. In conclusion, large volumes of liquids can safely be delivered via IT routes provided that ICP is monitored as a safety factor and cross-species physiological differences are accounted for.

摘要

越来越多的研究表明,鞘内注射(IT)途径将生物药物递送至中枢神经系统(CNS)的效力很高。我们早期的数据显示,输注体积和输注速率均可调节给药溶质在脑脊液(CSF)中的初始分布。这种分布是决定溶质随后向其预期靶点转运的关键因素之一。另一方面,快速向脑脊液中添加大量液体不可避免地会升高脑脊液压力[也称为颅内压(ICP)],如果超过生理限定阈值,这可能进而导致不良反应。虽然已知颅内压升高(脑积水)的长期生物学效应,但与鞘内给药引起的短期颅内压升高相关的安全阈值尚未明确。本研究旨在研究大鼠和非人灵长类动物(NHPs)颅内压随鞘内输注速率和体积的变化动态。对不同物种的安全范围进行了估计和分析,以促进转化性大容量鞘内治疗的发展。数据显示,向脑脊液中添加液体以速率和体积依赖性方式升高颅内压。在低输注速率下(大鼠<0.12 ml/分钟,非人灵长类动物<2 ml/分钟),非人灵长类动物和大鼠表现出相似的耐受模式。具体而言,这种添加体积的安全调节主要通过压力依赖性脑脊液加速引流至血液中实现,颅内压在大鼠低于28±4 mmHg和非人灵长类动物低于50±5 mmHg的不同安全阈值水平稳定。这些颅内压在延长的时间段(至少2 - 25分钟)内可安全耐受。高输注速率(包括推注)导致无法代偿的指数性颅内压升高,迅速超过安全阈值。它们的耐受性因物种而异,并由颅脊髓顺应性的不同组成部分的代偿作用促进,同时不排除其他促成因素的可能性。总之,只要将颅内压作为安全因素进行监测并考虑跨物种生理差异,就可以通过鞘内途径安全地输送大量液体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bf3/8079755/6187cd4d39f5/fnins-15-604197-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验